Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Events
  4.  » Tackling Bioavailability Challenges for the Next Generation of Small Molecules
Tackling Bioavailability Challenges for the Next Generation of Small Molecules

Date: February 16, 2023
Time: 11:00 am EST/ 5:00 pm CET

With small molecules continuing to make up the majority share of new drug approvals, the future is promising for oral drug development, and the innovation potential is significant. As new chemical modalities such as targeted protein degraders, covalent inhibitors, and RNA targeting small molecules, demonstrate the promise of clinical success, they also present new complexities in formulation and manufacturing requirements. As these new molecules continue to enable medical breakthroughs in therapeutic areas such as oncology, many require advanced formulation technologies to enhance bioavailability. Identifying the appropriate technology to overcome bioavailability challenges in early development is essential to avoiding expensive and lengthy development programs.
In this webinar, speakers will share industry insights into small molecule drug development advancements and discuss innovative, scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability.
In this webinar we will cover these key points:
  • Gain industry perspectives on the emerging classes of small molecules and their potential challenges for oral bioavailability
  • Understand the key challenges and advantages of the most preferred formulation technologies
  • Gain insight into how technology selection decisions made in early development can impact manufacturability





Brent Moody
Director, Scientific Advisory





Manuel Sanchez-Felix, PhD
Senior Fellow, Novel Delivery Technologies Group
Novartis Institutes for BioMedical Research